Livzon Pharmaceutical Group Inc. issued a supplemental announcement on 26 March 2026 to refine the proposed profit distribution plan for the financial year ended 31 December 2025.

The Board now specifies that a cash dividend of RMB14.30 (tax inclusive) will be paid for every 10 shares held, correcting any prior impression that RMB14.30 would be paid per single share. No bonus shares will be issued, and the capital reserve will not be converted into share capital.

The cash dividend will be calculated on the total share capital recorded on the equity registration date determined for the 2025 profit distribution. The proposal remains subject to approval at the forthcoming 2025 Shareholders’ Meeting.

All other information disclosed in the 24 March 2026 audited results announcement and the 2025 annual report remains unchanged.